Back to Sumitomo Mitsui Trust Group, Inc. Sumitomo Mitsui Trust Group, Inc.

NTLANTLA

Showing 9 of 31 quarters

Position history for Sumitomo Mitsui Trust Group, Inc.Sumitomo Mitsui Trust Group, Inc.'s holdings in Intellia Therapeutics, Inc.

Yes. Sumitomo Mitsui Trust Group holds 3,605,623 shares of NTLA (Intellia Therapeutics), worth $43.5M, as of its Q3 2026 13F filing. It increased the position by 708,094 shares (+24.4%) from Q2 2026. Sumitomo Mitsui Trust Group has held NTLA in every 13F on record since Q1 2019, 31 quarterly filings.

Current Value

$43.5M

Current Shares

3.6M

Total Value Change

-$21.2M

Total Shares Change

+456,224

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Increased
3.6M
+24.4%
$43.5M0.0%$12.06
36
2026-Q2
Increased
2.9M
+46.9%
$49M0.0%$16.92
40
2026-Q1
Decreased
2M
-10.0%
$25.3M0.0%$12.82
0
2025-Q4
Decreased
2.2M
-6.9%
$19.7M0.0%$8.99
0
2025-Q3
Decreased
2.4M
-11.8%
$40.7M0.0%$17.27
0
2025-Q2
Decreased
2.7M
-5.5%
$25.1M0.0%$9.38
0
2025-Q1
Decreased
2.8M
-5.6%
$20.1M0.0%$7.11
0
2024-Q4
Decreased
3M
-5.0%
$34.9M0.0%$11.66
0
2024-Q3
Decreased
3.1M
-3.3%
$64.7M0.0%$20.55
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used